Temozolomide & RT Followed by Dose Dense vs Temozolomide & Retinoic Acid in Pts w/Glioblastoma
Clinical trial NCT00200161 · COMPLETED
Trial details
- NCT number
- NCT00200161
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-08-09
- Primary completion
- 2017-05-04
- Enrollment
- 127
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.